POSTER SESSION II
Monday, March 3, 2008 — 1:00 PM - 4:30 PM
Convention Center, Exhibit Hall A
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
1
Characterization of the Expression of p-S6rb Protein, a Key Mediator of the mTOR Pathway, in Invasive Carcinomas of the Breast
(266)
AK Witkiewicz, CG Kleer - Thomas Jefferson University, Philadelphia, PA; University of Michigan, Ann Arbor, MI
The Use of p16INK4a, but Not p14ARF or p15INK4b as a Potential Marker for Breast and Ovarian Neoplasms
(238)
AN Shaye, D Rosen, J Liu - The University of Texas MD Anderson Cancer Center and Baylor College of Medicine, Houston, TX
Collagen a1 (XI) in Normal and Malignant Breast Tissue
(149)
KC Halsted - Northwest Nazarene University, Nampa, ID; Boise State University, Boise, ID; Mercy Medical Center, Nampa, ID
The Dynamic Biology of E-Cadherin and p120 Catenin: Development of a Dual Immunostain for Diagnostic Use in Breast Pathology
(93)
R Bhargava, D Tast, T Ewing-Finchem, K Obrecht, DJ Dabbs - Magee-Womens Hospital of UPMC, Pittsburgh, PA; Ventana Medical Systems, Tucson, AZ
GATA-3 as a Marker of Recurrence and Survival in Breast Cancer
(110)
V Ciocca, A Ruiz-Orrico, C Daskalakis, R Ciocca, J Palazzo - Thomas Jefferson University Hospital, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA
Loss of Heterozygosity of PTEN in Pregnancy-Associated Breast Cancer and Its Correlation with BRCA1/2, p53, NM23, Her-2 and Hormonal Status
(262)
BA Walter, VA Valera, F Tresserra, MJ Merino - National Cancer Institute, Bethesda, MD; Institut Universitari Dexeus, Barcelona, Spain
Down-Regulation of KAI-1 Expression in Low Grade Ductal Breast Carcinomas with and without Lymph Node Metastases
(191)
ML Lomme, MR Quddus, CJ Sung, F Liu, WD Lawrence - Women & Infants Hospital of Rhode Island, Providence, RI
The mRNA and Protein Expression of IGF1R in Early Breast Carcinoma: Association with Local Recurrence
(216)
G Peiro, S Benlloch, L Sanchez-Tejada, E Adrover, FM Peiro, E Lerma, FI Aranda - Hospital General Universitari, Alacant, Spain; Hospital de Sant Pau, Barcelona, Spain
Inactivation of RUNX3 by Frequent Promoter Hypermethylation and Protein Mislocalization Constitute an Early Event in Breast Cancer Progression
(220)
TC Putti, JY Chan, R Soong, M Salto-Tellez, K Ito, Y Ito, MM Subramaniam - Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; National University of Singapore, Singapore, Singapore; Institute of Molecular and Cell Biology, Singapore, Singapore
Value of Mammaglobin Immunostain in Estrogen Receptor Negative Metastatic Breast Carcinomas: A Comparative Analysis of 61 Cases
(223)
A Raghunathan, U Raju, D Schultz, A Ormsby, V Shah - Henry Ford Hospital, Detroit, MI
C1772T (P582S) or G1790A (A588T) Polymorphisms of HIF-1a Gene and HIF-1a Protein Expression in Breast Cancer Patients
(244)
JY Sung, HO Kim, GY Kim, S Lee, SJ Lim, JH Park, YK Park, YW Kim, JH Lee, SS Lee, I Kang, KS Yoon - College of Medicine, Kyung Hee University, Seoul, Korea; College of Medicine, Keimyung University, Daegu, Korea
Mutational Profile of RAS and BRAF Genes in Papillary Lesions of the Breast: Identification of a Common HRAS Mutation in Intracystic Papillary Carcinoma
(203)
N Nicosia Esposito, MN Nikiforova, YE Nikiforov, DJ Dabbs - Magee-Womens Hospital of the University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA
Aurora Kinases A and B Overexpression in Breast Cancer: Biological Significance and Clinical Implications
(134)
R Ghai, PB Rajan, K Foreman, TR Clements, U Kapur, K Yao, S Alkan - Loyola University Medical Center, Maywood, IL; University of Illinois at Chicago, Chicago
Stat3, Stat3-pY705 and P-c-Jun Expression in Bening Breast Tissue, In Situ and Invasive Ductal Carcinoma of the Breast
(193)
R Madan, M McLemore, FG Giancotti, MH Oktay - Montefiore Medical Center, Bronx, NY; Memorial Sloan-Kettering Cancer Center, New York, NY
Expression of Na+/I- Symporter Transmembrane Protein in Malignant and Benign Breast Epithelium: A Tissue Microarray Study
(169)
RE Jimenez, SJ Beyer, L Gentchev, SM Jhiang - The Ohio State University, Columbus, OH
Factors Associated with the Overexpression of the Independent Prognostic Marker eIF4E in Breast Cancer
(271)
S Zhang, A Agal, B Li, Q Chu, L Panu, C Meschonat, F Abreo - Lousiana State University Health Science Center, Shreveport, LA
Expression and Function of Androgen Receptor Co-Activator P44/MEP50 in Invasive Ductal Carcinoma of Breast
(186)
L Lin, Y Peng, J Wang, JJ Wei, L Chiriboga, B Singh, W Sun, W Gerald, P Lee - New York University, School of Medicine, New York, NY; Memorial Sloan-Kettering Cancer Center, New York, NY
Lower Levels of CD8+ Intratumoral T Cells Is Associated with Poor Prognosis in Breast Carcinoma of Premenopausal African American Women
(245)
K Suzue, I Gordon, M Tretiakova, XY Fu, T Krausz - University of Chicago Medical Center, Chicago, IL
UPARAP/Endo180 Expression in Invasive Breast Carcinoma and Its Relation to Patient Outcome
(122)
SE Elsheikh, AG Green, EA Rakha, RM Samaka, IO Ellis - Queen Medical Centre, Nottingham, United Kingdom; Queen Medcal Centre, Nottingham, United Kingdom; Menoufyia University, Menoufyia, Egypt
MyD88 Expression in Breast Cancer Is Associated with Poor Overall Survival Using an Objective and Quantitative (AQUA) Method of Analysis
(156)
M Harigopal, RL Camp, V Agnostou, G Mor, DL Rimm - Yale University School of Medicine, New Haven, CT
ESR1 Gene Amplification: A Common Phenomenon?
(225)
JS Reis-Filho, S Drury, M Lambros, C Marchio, K Savage, J Salter, M Dowsett - Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital Trust, London, United Kingdom
Co-Localization of Wilms' Tumor 1 with Maspin and p63 in Mammary Myoepithelial Cells
(256)
TN Vinh, MY Tata, YG Man - Armed Forces Institute of Pathology and American Registry of Pathology, Washington, DC
Subcellular Localization and Patterns of Expression of Fibroblast Growth Factor Receptor-1 and Its Phosphorylated Form FGFR1-pY653 in Human Breast Cancer
(105)
A Buyuk, R Keren, R Hazan, MH Oktay - Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
Periostin (POSTN, OSF2) Expression in Stroma of Normal Breast Tissue and Pre-Invasive Breast Lesions
(124)
I Espinosa, LC Collins, RB West, SJ Schnitt, M van de Rijn - Stanford University Medical Center, Palo Alto, CA; Beth Israel Deaconess Medical Center, Boston, MA
Clinicopathologic Features of Breast Carcinomas in Women Taking Postmenopausal Hormone Replacement Therapy
(197)
R Mathew, S Hoover, C Laronga, G Acs - H. Lee Moffitt Cancer Center, Tampa, FL
Breast Cancer in Women from Ghana and What It May Reveal about Breast Cancer in African-American Women
(99)
MB Braman, CG Kleer, LW Newman, I Martin, V Takyi - University of Michigan, Ann Arbor, MI
Breast Density, Calcifications, and Breast Cancer Subtypes among Premenopausal Women
(272)
Z Zhang, U Raju, M Burke, D Schultz, M Zarbo, M Linden, A Stark - Henry Ford Health System, Detroit, MI
Lobular Involution and Subsequent Breast Cancer Risk: Findings from the Nurses' Health Studies
(84)
H Baer, L Collins, J Connolly, G Colditz, S Schnitt, R Tamimi - Brigham and Women's Hospital, Boston; Harvard School of Public Health, Boston; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Alvin J. Siteman Cancer Center and Washington Univ School of Medicine, St. Louis, MO
Longitudinal Analysis of Benign Breast Disease in Women Developing Breast Cancer after a Benign Biopsy: A Mayo Breast Disease Cohort Study
(257)
DW Visscher, C Reynolds, RA Vierkant, MH Frost, LC Hartmann - University of Michigan Health Systems, Ann Arbor, MI; Mayo Clinic, Rochester, MN
KAI-1 Expression in Proliferative, Non-Neoplastic Lesions of the Breast
(190)
ML Lomme, MR Quddus, CJ Sung - Women & Infants Hospital of Rhode Island, Providence, RI
button next to any title to add to Itinerary Planner...
Add
